Last reviewed · How we verify

Deoxycortone Pivalate (DESOXYCORTICOSTERONE PIVALATE)

Novartis · FDA-approved approved Small molecule Quality 10/100

At a glance

Generic nameDESOXYCORTICOSTERONE PIVALATE
SponsorNovartis
Drug classdesoxycorticosterone pivalate
TargetMineralocorticoid receptor
ModalitySmall molecule
Therapeutic areaHematology
PhaseFDA-approved
First approval1982

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results